94 related articles for article (PubMed ID: 35238754)
1. The relationship between metabolic syndrome severity and the risk of mortality in gout patients: a population-based study.
Schlesinger N; Elsaid MI; Rustgi VK
Clin Exp Rheumatol; 2022 Mar; 40(3):631-633. PubMed ID: 35238754
[TBL] [Abstract][Full Text] [Related]
2. A metabolic syndrome severity score: A tool to quantify cardio-metabolic risk factors.
Wiley JF; Carrington MJ
Prev Med; 2016 Jul; 88():189-95. PubMed ID: 27095322
[TBL] [Abstract][Full Text] [Related]
3. The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.
Vishnu A; Gurka MJ; DeBoer MD
Atherosclerosis; 2015 Nov; 243(1):278-85. PubMed ID: 26409627
[TBL] [Abstract][Full Text] [Related]
4. Gender difference in the association between gout at diagnosis and metabolic syndrome in African population: a retrospective cohort study.
Lekpa FK; Bebey FS; Bouallo I; Njonnou SRS; Luma HN; Singwe-Ngandeu M; Choukem SP
Pan Afr Med J; 2022; 43():164. PubMed ID: 36825121
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome severity score (MetSSS) associates with metabolic health status in multi-ethnic Aotearoa New Zealand cohorts.
Merry TL; Metcalf P; Scragg R; Gearry R; Foster M; Krebs JD
Diabetes Res Clin Pract; 2022 Oct; 192():110088. PubMed ID: 36154929
[TBL] [Abstract][Full Text] [Related]
6. Physical activity and metabolic syndrome severity among older adults at cardiovascular risk: 1-Year trends.
Gallardo-Alfaro L; Bibiloni MDM; Bouzas C; Mascaró CM; Martínez-González MÁ; Salas-Salvadó J; Corella D; Schröder H; Martínez JA; Alonso-Gómez ÁM; Wärnberg J; Vioque J; Romaguera D; Lopez-Miranda J; Estruch R; Tinahones FJ; Lapetra J; Serra-Majem L; Bueno-Cavanillas A; Micó RM; Pintó X; Gaforio JJ; Ortíz-Ramos M; Altés-Boronat A; Luca BL; Daimiel L; Ros E; Sayon-Orea C; Becerra-Tomás N; Gimenez-Alba IM; Castañer O; Abete I; Tojal-Sierra L; Pérez-López J; Torres-Collado L; Colom A; Garcia-Rios A; Castro-Barquero S; Bernal R; Santos-Lozano JM; Fernandez-Lazaro CI; Hernández-Alonso P; Saiz C; Zomeño MD; Zulet MA; Belló-Mora MC; Basterra-Gortari FJ; Canudas S; Goday A; Tur JA;
Nutr Metab Cardiovasc Dis; 2021 Sep; 31(10):2870-2886. PubMed ID: 34366176
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome positively correlates with the risks of atherosclerosis and diabetes in a Chinese population.
Tsai SS; Lin YS; Chen ST; Chu PH
Eur J Intern Med; 2018 Aug; 54():40-45. PubMed ID: 29655805
[TBL] [Abstract][Full Text] [Related]
8. Low serum high density lipoprotein is associated with the greatest risk of metabolic syndrome among U.S. adults.
Castaneda G; Bhuket T; Liu B; Wong RJ
Diabetes Metab Syndr; 2018; 12(1):5-8. PubMed ID: 28826579
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Metabolic Syndrome in Predicting Mortality Risk Among US Adults: Importance of Metabolic Syndrome Even in Adults With Normal Weight.
Shi TH; Wang B; Natarajan S
Prev Chronic Dis; 2020 May; 17():E36. PubMed ID: 32441641
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the link between metabolic syndrome and abdominal aortic calcification.
Yang SW; Yang HF; Chen YY; Chen WL
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):464-471. PubMed ID: 33223398
[TBL] [Abstract][Full Text] [Related]
11. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES).
Oye-Somefun A; Kuk JL; Ardern CI
BMC Cardiovasc Disord; 2021 Jul; 21(1):352. PubMed ID: 34311708
[TBL] [Abstract][Full Text] [Related]
12. Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study.
DeBoer MD; Gurka MJ; Woo JG; Morrison JA
Diabetologia; 2015 Dec; 58(12):2745-52. PubMed ID: 26380985
[TBL] [Abstract][Full Text] [Related]
13. Gender- and race-specific metabolic score and cardiovascular disease mortality in adults: A structural equation modeling approach--United States, 1988-2006.
Mercado CI; Yang Q; Ford ES; Gregg E; Valderrama AL
Obesity (Silver Spring); 2015 Sep; 23(9):1911-9. PubMed ID: 26308480
[TBL] [Abstract][Full Text] [Related]
14. Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity.
DeBoer MD; Filipp SL; Sims M; Musani SK; Gurka MJ
Stroke; 2020 Aug; 51(8):2548-2552. PubMed ID: 32552367
[TBL] [Abstract][Full Text] [Related]
15. Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014.
Shin D; Kongpakpaisarn K; Bohra C
Int J Cardiol; 2018 May; 259():216-219. PubMed ID: 29472026
[TBL] [Abstract][Full Text] [Related]
16. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
17. Components of the metabolic syndrome differ between young and old adults in the US population.
Sumner AD; Sardi GL; Reed JF
J Clin Hypertens (Greenwich); 2012 Aug; 14(8):502-6. PubMed ID: 22863157
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use.
Novak S; Melkonian AK; Patel PA; Kleinman NL; Joseph-Ridge N; Brook RA
Curr Med Res Opin; 2007 Mar; 23(3):623-30. PubMed ID: 17355743
[TBL] [Abstract][Full Text] [Related]
19. Incidence and long-term specific mortality trends of metabolic syndrome in the United States.
Li W; Qiu X; Ma H; Geng Q
Front Endocrinol (Lausanne); 2022; 13():1029736. PubMed ID: 36733801
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome in primary health settings in Qatar: a cross sectional study.
Syed MA; Al Nuaimi AS; Latif Zainel AJA; A/Qotba HA
BMC Public Health; 2020 May; 20(1):611. PubMed ID: 32362284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
